Diferencia entre revisiones de «Template:Seizure DDX»
Sin resumen de edición |
|||
| Línea 13: | Línea 13: | ||
**[[Alcohol withdrawal]] | **[[Alcohol withdrawal]] | ||
**Benzodiazepine withdrawal | **Benzodiazepine withdrawal | ||
**Metabolic abnormalities: [[hyponatremia]], [[hypernatremia]], [[hypocalcemia]], [[hypomagnesemia]], [[hypoglycemia]], [[hyperglycemia]], [[hepatic failure]] | **[[Barbiturate withdrawal]] | ||
**[[Baclofen withdrawal]] | |||
**Metabolic abnormalities: [[hyponatremia]], [[hypernatremia]], [[hypocalcemia]], [[hypomagnesemia]], [[hypoglycemia]], [[hyperglycemia]], [[hepatic failure]], [[uremia]] | |||
**[[Eclampsia]] | **[[Eclampsia]] | ||
**[[Cysticercosis|Neurocysticercosis]] | **[[Cysticercosis|Neurocysticercosis]] | ||
**[[Posterior reversible encephalopathy syndrome]] | **[[Posterior reversible encephalopathy syndrome]] | ||
**Impact seizure ([[head trauma]]) | **Impact seizure ([[head trauma]]) | ||
**Acute [[hydrocephalus]] | |||
**[[Arteriovenous malformation]] | |||
**Seizure with [[VP shunt]] | **Seizure with [[VP shunt]] | ||
**[[Toxic ingestion]] (amphetamines, anticholinergics, cocaine, INH, organophosphates, TCA, salicylates, lithium, phenothiazines) | **[[Toxic ingestion]] (amphetamines, anticholinergics, cocaine, INH, organophosphates, TCA, salicylates, lithium, phenothiazines, bupropion, camphor, clozapine, cyclosporine, fluoroquinolones, imipenem, lead, lidocaine, metronidazole, synthetic cannabinoids, theophylline) | ||
**[[Psychogenic nonepileptic seizure]] (pseudoseizure) | **[[Psychogenic nonepileptic seizure]] (pseudoseizure) | ||
*[[Intracranial mass]] | *[[Intracranial mass]] | ||
Revisión del 20:09 2 sep 2019
Seizure
- Epileptic seizure
- First-time seizure
- Seizure with known seizure disorder
- Status epilepticus
- Temporal lobe epilepsy
- Non-compliance with anti-epileptic medications
- Non-epileptic seizure
- Meningitis
- Encephalitis
- Brain abscess
- Intracranial hemorrhage
- Alcohol withdrawal
- Benzodiazepine withdrawal
- Barbiturate withdrawal
- Baclofen withdrawal
- Metabolic abnormalities: hyponatremia, hypernatremia, hypocalcemia, hypomagnesemia, hypoglycemia, hyperglycemia, hepatic failure, uremia
- Eclampsia
- Neurocysticercosis
- Posterior reversible encephalopathy syndrome
- Impact seizure (head trauma)
- Acute hydrocephalus
- Arteriovenous malformation
- Seizure with VP shunt
- Toxic ingestion (amphetamines, anticholinergics, cocaine, INH, organophosphates, TCA, salicylates, lithium, phenothiazines, bupropion, camphor, clozapine, cyclosporine, fluoroquinolones, imipenem, lead, lidocaine, metronidazole, synthetic cannabinoids, theophylline)
- Psychogenic nonepileptic seizure (pseudoseizure)
- Intracranial mass
- Syncope
- Hyperventilation syndrome
- Migraine headache
- Movement disorders
- Narcolepsy/cataplexy
- Post-hypoxic myoclonus (Status myoclonicus)